Iterum Therapeutics plc (Nasdaq: ITRM), a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today announced that Corey Fishman, Chief Executive Offer at Iterum Therapeutics, will provide a company overview and business update at the 19th Annual Needham Virtual Healthcare Conference
April 9, 2020
· 4 min read